Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

1.0K
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

404
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
404
Teratogenicity01:07

Teratogenicity

4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

552
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
552
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

960
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
960

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk of Major Malformations Following First-Trimester Exposure to Cariprazine: Preliminary Data From the MGH National Pregnancy Registry for Psychiatric Medications.

Bipolar disorders·2026
Same author

Pregnancy Outcomes After First-Trimester Exposure to Vortioxetine: Prospective Outcomes From the MGH National Pregnancy Registry for Psychiatric Medications.

Journal of clinical psychopharmacology·2026
Same author

The effect of cumulative trauma load on suicide risk and thoughts in trauma-exposed youth over two years.

Journal of affective disorders·2026
Same author

Mechanisms, prevention, and management of aminoglycoside-induced hearing loss in neonates and children: a translational review.

Frontiers in pharmacology·2026
Same author

When risks outweigh benefits: A review of the guideline on benzodiazepine tapering.

Cleveland Clinic journal of medicine·2026
Same author

Maternal and umbilical cord plasma concentrations of antiseizure medications: Results from the observational MONEAD study.

Epilepsia·2026
Same journal

Acute Kidney Injury After Mechanical Thrombectomy for Stroke in Patients With Pre-Existing Renal Impairment.

Annals of clinical and translational neurology·2026
Same journal

Gravity-Dependent Modulation of Downbeat Nystagmus: Insights From Velocity-Storage Dysfunction.

Annals of clinical and translational neurology·2026
Same journal

Temporal Interference Stimulation of Centromedian-Parafascicular Complex in Disorders of Consciousness: A Pilot Study.

Annals of clinical and translational neurology·2026
Same journal

Global Rather Than Vertical-Selective Saccadic Abnormalities in Progressive Supranuclear Palsy.

Annals of clinical and translational neurology·2026
Same journal

Factors Associated With the Rising Trend in Self-Reported Cognitive Disability Among U.S. Adults Aged 18-39 From 2013-2024.

Annals of clinical and translational neurology·2026
Same journal

Bi- and Mono-Allelic RFC1 Expansion in a North American Cohort With Idiopathic Axonal Neuropathy.

Annals of clinical and translational neurology·2026
See all related articles

Related Experiment Video

Updated: Apr 28, 2026

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
11:08

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy

Published on: March 13, 2014

30.1K

MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATION.

Akshanth R Polepally1, Page B Pennell2, Richard C Brundage1

  • 1Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota.

Annals of Clinical and Translational Neurology
|June 3, 2014
PubMed
Summary
This summary is machine-generated.

Pregnancy significantly increases lamotrigine (LTG) oral clearance (CL/F) in most women, necessitating dosage adjustments. Postpartum LTG levels return to baseline within three weeks, requiring dose tapering.

More Related Videos

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
12:17

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

10.0K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

811

Related Experiment Videos

Last Updated: Apr 28, 2026

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
11:08

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy

Published on: March 13, 2014

30.1K
The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
12:17

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

10.0K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

811

Area of Science:

  • Pharmacokinetics
  • Maternal-Fetal Medicine
  • Clinical Pharmacology

Background:

  • Lamotrigine (LTG) is an antiepileptic drug commonly used during pregnancy.
  • Understanding changes in LTG pharmacokinetics during pregnancy is crucial for effective treatment and patient safety.

Purpose of the Study:

  • To characterize the changes in lamotrigine oral clearance (CL/F) throughout pregnancy and the postpartum period.
  • To develop a model-based approach to guide clinical management of LTG therapy in pregnant women.
  • To identify clinical characteristics influencing LTG CL/F during gestation.

Main Methods:

  • A population pharmacokinetic analysis using a nonlinear, mixed-effects model was employed.
  • Data included 600 LTG concentrations from 60 women across 64 pregnancies.
  • Maternal blood samples were collected serially throughout pregnancy.

Main Results:

  • Baseline LTG CL/F was 2.16 L/h, with significant inter-individual variability.
  • Pregnancy led to a substantial increase in LTG CL/F, particularly in 77% of women (0.118 L/h/week).
  • Increased CL/F returned to baseline postpartum with a half-life of 0.55 weeks.

Conclusions:

  • The majority of pregnant women experience a significant increase in LTG CL/F, potentially leading to subtherapeutic concentrations.
  • Close monitoring and frequent dosage adjustments are recommended for pregnant women on LTG, especially in the third trimester.
  • Postpartum LTG doses should be carefully tapered to preconception levels within three weeks of delivery.